eHealth2030

eHealth Ventures, based in Tel Aviv, Israel, is a venture capital firm specializing in early-stage digital health investments. With $70 million in assets under management, the firm focuses on pre-seed, seed, and early-stage companies. They have a diverse portfolio of 28 investments, emphasizing innovative healthcare solutions and technologies. Notable investments by eHealth Ventures include IdentifAI, a company offering non-invasive prenatal genetic screening, and Olive Diagnostics, which has developed the first 100% passive, non-invasive urinalysis device for home use. Other significant investments are Agamon, which uses AI to improve operational workflows in healthcare, and GaitBetter, providing virtual reality solutions for brain-training and healthy mobility. eHealth Ventures works closely with strategic healthcare partners to support clinical integration, business validation, and commercial expansion of their portfolio companies. This collaborative approach helps them leverage resources and expertise to accelerate the growth and impact of their investments​.